Many health and wellness stocks have faced challenges in recent years as GLP-1 weight-loss drugs like Ozempic and Wegovy upend the traditional diet market. Companies that once dominated the space have ...

WeightWatchers’ stock was surging after the company emerged from bankruptcy two months after it was announced.

Weight Watchers went bankrupt in May, but now it promises it's trimmed the fat off its books and is ready to rejoin the ...

With new leadership and a Nasdaq relisting plan, the iconic brand is betting on women’s health and weight loss drugs to stage a comeback.

Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 4.1% in the morning session after the company ...

WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

WeightWatchers appointed Dr. Kim Boyd as its chief medical officer on Tuesday. She will be the second person to ever hold the ...

The decline of real-life slimming clubs is down to a variety of factors, says Kate. ‘Diets come in fads — at the moment, ...

The partnership helps Novo capture patients who have been using compounded versions of the medicine, while allowing ...

WeightWatchers on Tuesday named Dr. Kim Boyd as chief medical officer and said it was planning a new program to help women manage the transition into menopause and beyond, as part of its growth ...

WW's bankruptcy filing followed a turbulent spell marked by disappointing results, staff cuts and turnover at the top. In August 2024, the company's stock fell below $1 for the first time.

WeightWatchers’ stock was surging after the company emerged from bankruptcy two months after it was announced. WeightWatchers emerges from bankruptcy, and it’s now taking aim at menopause Share ...